Title | Cooperative ETS Transcription Factors Enforce Adult Endothelial Cell Fate and Cardiovascular Homeostasis. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Gomez-Salinero JM, Itkin T, Houghton S, Badwe C, Lin Y, Kalna V, Dufton N, Peghaire CR, Yokoyama M, Wingo M, Lu TM, Li G, Xiang JZhaoying, Hsu Y-MSheng, Redmond D, Schreiner R, Birdsey GM, Randi AM, Rafii S |
Journal | Nat Cardiovasc Res |
Volume | 1 |
Pagination | 882-899 |
Date Published | 2022 Oct |
ISSN | 2731-0590 |
Abstract | <p>Current dogma dictates that during adulthood, endothelial cells (ECs) are locked in an immutable stable homeostatic state. By contrast, herein we show that maintenance of EC fate and function are linked and active processes, which depend on the constitutive cooperativity of only two ETS-transcription factors (TFs) ERG and Fli1. While deletion of either Fli1 or ERG manifest subtle vascular dysfunction, their combined genetic deletion in adult EC results in acute vasculopathy and multiorgan failure, due to loss of EC fate and integrity, hyperinflammation, and spontaneous thrombosis, leading to death. ERG and Fli1 co-deficiency cause rapid transcriptional silencing of pan- and organotypic vascular core genes, with dysregulation of inflammation and coagulation pathways. Vascular hyperinflammation leads to impaired hematopoiesis with myeloid skewing. Accordingly, enforced ERG and FLI1 expression in adult human mesenchymal stromal cells activates vascular programs and functionality enabling engraftment of perfusable vascular network. GWAS-analysis identified vascular diseases are associated with FLI1/Erg mutations. Constitutive expression of ERG and Fli1 uphold EC fate, physiological function, and resilience in adult vasculature; while their functional loss can contribute to systemic human diseases.</p> |
DOI | 10.1038/s44161-022-00128-3 |
Alternate Journal | Nat Cardiovasc Res |
PubMed ID | 36713285 |
PubMed Central ID | PMC7614113 |
Grant List | FS/15/65/32036 / BHF_ / British Heart Foundation / United Kingdom FS/PHD/22/29242 / BHF_ / British Heart Foundation / United Kingdom RG/17/4/32662 / BHF_ / British Heart Foundation / United Kingdom U01 AI138329 / AI / NIAID NIH HHS / United States RG/11/17/29256 / BHF_ / British Heart Foundation / United Kingdom R35 HL150809 / HL / NHLBI NIH HHS / United States PG/13/53/30351 / BHF_ / British Heart Foundation / United Kingdom RC2 DK114777 / DK / NIDDK NIH HHS / United States |